# A Study of Prevalence of EGFR Mutations in Participants With NSCLC

> **NCT02695849** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 69 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02695849
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695849, "A Study of Prevalence of EGFR Mutations in Participants With NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02695849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*